Effects of Dosin in Helicobacter pylori infectio
Phase 2
- Conditions
- Helicobacter pylori infection.Helicobacter pylori [H.pylori] as the cause of diseases classifiedB 98.0
- Registration Number
- IRCT201209041957N3
- Lead Sponsor
- Research Institute for Islamic and Complementary Medicine, Tehran Unive
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
20-60 years old, documented helicobacter pylori infection and functional dyspepsia.
Exclusion criteria: pregnancy, breast feeding, duodenal or gastric ulcer, cancer or bleeding, usage of NSAIDs, corticosteroids, bismuth, antibiotics, proton pomp inhibitors and anticoagulants 4 weeks before the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori infection. Timepoint: Six weeks after beginning of intervention. Method of measurement: Urea Breath Test.
- Secondary Outcome Measures
Name Time Method Dyspepsia. Timepoint: Six weeks after beginning of intervention. Method of measurement: Dyspepsia questionnaire.